Ask AI
ProCE Banner Activity

Focus on the Postacute Phase Transcript: Considerations for Optimizing Outpatient Antivirals to Mitigate the Long-term Impact of COVID-19 

PDF

Learn how early treatment for COVID-19 and keeping up with booster vaccinations can mitigate much of the risk for long COVID in high-risk populations. 

Released: February 27, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Target Audience

This activity is intended for healthcare professionals including primary care providers, geriatricians, urgent care providers, internal medicine specialists, and infectious diseases specialists who provide care for patients at risk for severe COVID-19 outcomes. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate the latest clinical data on long-term COVID-19 outcomes into management strategies for high-risk populations 

Disclosure

Primary Author

Yohei Doi, MD, PhD, FIDSA: consultant/advisor/speaker: Becton Dickinson, Chugai, Gilead, GSK, Meiji Seika Pharma, Shionogi.